Cartesian Therapeutics (RNAC)

• Market cap: $172M
• 1 day: 1.38%
• 5 days: -10.81%
• 1 month: -5.44%
• 3 months: 2.64%
• 6 months: -32.72%
• Year to date: -2.37%
• 1 year: -58.59%
• 5 years: -95.13%
• 10 years: -98.43%
• Sector: Healthcare
• Industry: Biotechnology

About: Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Employees: 66